F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review the facility failed to document appropriate indications to warrant
the use of an antipsychotic medication (R46) and attempt a gradual dose reduction (R19) for 2 of 5
residents reviewed for unnecessary medication in a sample of 23.
Findings include:
A Psychotropic Medication policy dated 11/28/17 gives as its intent, Residents are free from unnecessary
psychotropic medication use. This policy states that antipsychotic medication may be indicated for use if
behavioral symptoms present a danger to the resident or others; expressions or indications of distress that
are significant distress to the resident; if not clinically indicated, multiple non-pharmacological approaches
have been attempted but did not relieve the symptoms which are presenting a danger or significant
distress; and /or a gradual dose reduction (GDR) was attempted, but clinical symptoms returned. In
addition, this policy states that a GDR must be attempted annually, unless contraindicated.
1. R46's list of current diagnoses includes Unspecified Dementia, Unspecified Severity, with other
behavioral disturbance, Depression, and Anxiety disorder.
R46's physician's order (POS) dated 6/20/23 documents R46 was prescribed the antipsychotic medication
Seroquel 25 mg (milligrams) two times daily for the diagnosis of Unspecified Dementia, Unspecified
Severity, with other behavioral disturbance.
R46's physician's visit notes dated 6/2/23 instructs staff to use the diagnosis, Dementia (with) behaviors for
her Seroquel.
R46's Physical Device/Psychoactive Medication Initial and Quarterly Evaluation dated 6/20/23 documents
R46 has the mental status of being alert, disoriented, with a short attention span. This same evaluation
documents that R46 has the emotional, environmental, and social considerations of toileting difficulties,
dependence on staff for turning and repositioning, and feelings of anger, loneliness, and abandonment. This
same evaluation includes an area for defined recommendations/alternatives and individualized alternatives
to administering psychoactive medications to R46, however, the only recommendation made was for family
visits which, this evaluation documents, have been effective as an alternative to medications. In addition,
R46's psychoactive medication evaluation documents the indication to warrant R46's use of an
antipsychotic medication as dementia with behavior disorder.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
146042
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146042
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
H & J Vonderlieth Lvg Ctr, The
1120 North Topper Drive
Mount Pulaski, IL 62548
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
R46's Antipsychotic Medication Consent dated 6/20/23 documents R46 has the diagnosis or medical
symptom of dementia with behaviors as an indication for the use of Seroquel.
R46's care plan dated 2/28/23 documents that R46 was prescribed an antipsychotic medication. This same
care plan instructs for staff to monitor R46 for the target behaviors of pacing, disrobing, inappropriate
response to verbal communication, violence/aggression towards others. R46's care plan dated 3/29/23
documents R46 has the behaviors of hitting and slapping at staff during cares and using abusive language,
screaming, crying out, and hollering.
R46's Behavior Monitoring and Interventions Report dated 4/1/23 to 8/2/23 documents R46 had behaviors
on four dates which included physical and verbal behaviors directed towards others, sad, tearful, agitated,
refusing care,
R46's Minimum Data Set (MDS) assessment dated [DATE] documents R46 is severely cognitively impaired
and had no behaviors during the look-back period of this assessment. This same assessment documents
R46's behavior was unchanged from the previous assessment.
On 7/31/23 at 1:35 p.m. R46 was seated in a wheelchair in the activities room drinking a cup of coffee
surrounded by other residents. R46 was confused but calm and relaxed with a pleasant demeanor. R46
was able to answer some simple questions and stated she was tired that morning.
On 8/2/23 at 9:25 a.m. R46 was seated in a wheelchair in the activities room waiting for the activity of 50's
music to begin. R46 was surrounded by other residents but remained calm and relaxed with a pleasant
demeanor. At 9:26 a.m. V6 (Certified Nurse Aide/ CNA) stated that R46 sometimes has behaviors which
usually occur while staff are providing R46 with care. V6 stated R46's behaviors during care are usually
yelling and crying. V6 stated that one way to prevent R46 from having behaviors is for staff to wait until R46
decides she is ready to get up in the morning by watching for R46 to sit up at the side of the bed. V6 stated
another way to help prevent R46 from having behaviors is to give R46 a cup of coffee stating, She loves
coffee. V6 stated that R46's behaviors are unchanged since R46's admission 2/28/23.
On 8/2/23 at 9:35 a.m. V5 (Licensed Practical Nurse/LPN) stated that he is R46's nurse and also serves as
the MDS Coordinator. V5 verified that R46's diagnosis for the use of Seroquel is behavioral disturbances
with Dementia. V5 stated that R46's behaviors include physical and verbal behaviors towards staff during
cares. V5 stated when R46 has behaviors, staff will try to reapproach R46 at another time, try using
soothing speech to talk with R46, provide snacks or leave R46 in a safe area to relax.
2. R19's list of current diagnoses includes Alzheimer's disease, Major Depressive disorder, single episode;
Delusional disorder, Dementia with behavioral disturbances.
R19's physician's order (POS) dated 8/2/22 documents R19 was prescribed the antipsychotic medication
Seroquel 25 mg (milligrams) 1/2 tablet every Monday, Tuesday, Thursday, Friday, Saturday in the evening for
the diagnosis of Delusional Disorder.
A pharmacy comprehensive list of R19's psychotropic orders dated 7/1/23 to 7/24/23 documents R19's
original physician's order for Seroquel 25 mg ½ tablet every evening five times per week was written
1/26/18 with the most recent gradual dose reduction attempted 8/2/22.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146042
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146042
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
H & J Vonderlieth Lvg Ctr, The
1120 North Topper Drive
Mount Pulaski, IL 62548
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
R19's Minimum Data Set (MDS) assessment dated [DATE] documents that R19 is rarely or never
understood and rarely or never understands. This same MDS documents R19 is moderately cognitively
impaired and displayed no behaviors during the MDS look-back period.
R19's Physical Device/Psychoactive Medication Initial and Quarterly Evaluation dated 7/17/23 documents
R19's most recent gradual dose reduction of Seroquel occurred 8/2/22.
R19's Behavior Monitoring and Interventions Report dated 4/3/23 to 8/2/23 document that during those
dates, R19 did not have any behaviors.
On 8/02/23 at 9:20 a.m. V6 (Certified Nurse Aide) stated that R19 does not usually have behaviors and is
cooperative with cares.
On 8/02/23 at 9:38 a.m. V5 (Licensed Practical Nurse/ MDS Coordinator) and V4 (Social Services Director)
were standing next to the nurses' station. V5 stated R19 has behaviors towards staff during cares and is
prescribed the antipsychotic medication Seroquel. V4 stated R19 has delusions, hallucinations, and has
conversations with an invisible person. V4 stated that R19's delusions and hallucinations are not distressing
to R19.
On 8/3/23 V2 (Director of Nurses) stated she manages psychoactive medications for the facility. V2 stated
the facility does not have a specific protocol for performing GDRs for antipsychotic medications but, instead,
they rely on their pharmacy to recommend when GDRs should be attempted. V2 stated that residents who
have been taking an antipsychotic one year or more do not necessarily require an annual GDR. V2 stated
that the R46's indications of Dementia with behaviors used to warrant the use of the antipsychotic Seroquel
were appropriate.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146042
If continuation sheet
Page 3 of 3